Navigation Links
Tissue Engineering Shows Promise to Revolutionize Transplant Medicine

SAN DIEGO, April 13, 2011 /PRNewswire/ -- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.  While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Sessions this week.

"We have opened the door to generating new complex organs," said Doris A. Taylor, PhD, University of Minnesota.

Dr. Taylor will moderate Thursday's Mid-Day Symposium 3: Immunological Aspects of Engineered Heart Tissue and Cellular Replacement Therapies in Heart Failure.

According to Dr. Taylor, creating bioartificial organs requires cells, a framework for the cells and a way to feed these cells. Building any complex organ, a heart or lung for instance, requires a complex interplay between cells, their microenvironments and the vascular network, which ultimately impacts cell differentiation.

Beyond transplantation, tissue engineering holds potential for building pieces of organs and tissues for use in repair of these organs.

On Friday, Dr. Taylor will discuss her own research during the Mid-Day Symposium 5:  Future Therapies for End-Stage Thoracic Organ Failure. Dr. Taylor's discussion: Is There a Future for Engineered Heart and Lung, will explore how matrix provides an architecturally correct 3-D microenvironment for developing cells and the biologic structural cues that drive cell behavior. She will discuss the impact of matrix on stem or progenitor cell alignment, differentiation, function and physiology, as well as its use as an in vitro test bed to evaluate stem cell repair.

"Engineering solutions to disease is no longer science fiction. Tissue engineering has the potential to revolutionize how humans think of health and disease," said Dr. Taylor.

Dr. Taylor noted that tracheas and bladders from decellularized matrix are already in clinical study. As the field advances, progressively more complex organs will be transplanted.

"Our hope is that this technology will make end stage heart and lung disease a problem of the past.  We are working towards generating autologous organs and reducing the burden of organ rejection," Dr. Taylor continued.


The International Society for Heart & Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases.  Established in 1981, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT maintains two vital databases.  The International Heart &  Lung Transplant Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries.  The ISHLT Mechanical Circulatory Support Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation; generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices.  In Fall 2006, ISHLT released the first international guidelines for heart failure patient management.  For more information, visit

Contact:  Megan Augustine
(210) 296-9520

SOURCE International Society for Heart & Lung Transplantation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells
2. Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model
3. Global Cell/Tissue Culture Supplies Industry
4. Healthier Healing for Hip Resurfacing - ICAP Ocean Tomo Announces Auction of an Advanced Hip Cap for Electromagnetic Tissue Stimulation by Neue Magnetodyn.
5. Caliper Life Sciences and HistoRx to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue
6. Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
7. Leaders of Health in High-Def Grow Tissue to Get Patients Back on Their Feet
8. BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions
9. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
10. Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh
11. Reportlinker Adds European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):